How is Adamax dosed and mixed?

500 mcg of Adamax from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.

Every vial at a glance. Pick a cell to draw it on the syringe.

Concentration is the vial's amount over its water; units are the dose over the concentration, times 100, on a U-100 syringe.
Vial1 mL of water2 mL of water
5 mg5 mg/mL: 400 mcg is 8 units, 500 mcg is 10 units2.5 mg/mL: 400 mcg is 16 units, 500 mcg is 20 units
10 mg10 mg/mL: 400 mcg is 4 units, 500 mcg is 5 units5 mg/mL: 400 mcg is 8 units, 500 mcg is 10 units

Jump to a vial 5 mg 10 mg

No Adamax label or trial gives a dose; for Semax, Gusev's 2018 trial in one hundred and ten people after ischemic stroke, split into groups with and without Semax, gave 6000 mcg/day in 2 courses of 10 days with a 20-day interval.1

Vial mixes and syringe units

Searches found no Adamax vial strength or water volume from a label, trial or maker's leaflet; vendor, wiki and calculator pages were not used as sources. The vials, water volumes and doses in the table, the worked example and the calculator are example figures worked as arithmetic, not sourced Adamax products or doses. The examples follow what people log for Semax, not Adamax: 45% of people logging Semax set up a 10 mg vial with 2 mL of water, and 36% logged 500 mcg.5 FDA's briefing, based on reports in most publicly available literature, gives Semax free base as soluble in water up to 2 mg/mL and approximately 10 mg/mL in phosphate-buffered saline.2 Every mix in the table works out above that 2 mg/mL figure for Semax.2

500 mcg of Adamax from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.

500 mcg of Adamax from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.

Doses, schedules and routes

No Adamax dose, schedule or cycle length comes from a label or trial. The figures in the table are for Semax; no label or trial found gives a figure for Adamax.

SourceDose and schedulePeopleLength
Gusev, 201816000 mcg/day, 2 courses, 20-day interval; route not givenOne hundred and ten after ischemic stroke, in groups with and without Semax (sizes not given)10 days a course
Serdiuk, 2007, open label31% Semax intranasally, 12 mg daily, two courses with a 2-week break27 with motor neuron disease10 days a course

FDA's briefing says the Semax products nominated for compounding were an intranasal spray or a subcutaneous injection at 7,500 or 1,000 µg/mL.2 Searches returned no Adamax route from a label or trial.

Storage

Searches returned no Adamax storage conditions. For Semax free base, FDA's briefing reports the lyophilised powder stable 4 years at -20°C in a tightly closed container, and the reconstituted solution kept at +4°C for up to 2–7 days.2 For Semax acetate, the briefing cites a certificate of analysis giving long-term storage in a sealed container at 2°C to 8°C.2

Frequently asked questions

Is there an Adamax label or human trial?

Searches of DailyMed, FDA's briefing documents and the Russian register returned no Adamax label or regulator record. Searches of ClinicalTrials.gov and PubMed returned no human trial of Adamax.

Is Adamax the same as Semax?

FDA's briefing names Semax-related substances and not Adamax.4

What is not known about Adamax?

Searches of PubMed returned no Adamax stability, pharmacokinetic or safety data. FDA says Semax free base and Semax acetate are not well characterised from a physical and chemical perspective, lacking endotoxin data for injectable routes and information on choosing a container and pump for a nasal spray.2

How the logged figures are counted

Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.

References

  1. PubMed. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]. 2018. pubmed.ncbi.nlm.nih.gov
  2. FDA. FDA Briefing Document. 2026. fda.gov
  3. PubMed. [The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax]. 2007. pubmed.ncbi.nlm.nih.gov
  4. FDA. FDA Briefing Document. 2026. fda.gov
  5. Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted